{{knowledge objective
|Identifiant=OIC-080-09-B
|Item_parent=Doping and doping behaviour. (see item 256)
|Item_parent_short=Doping and doping behaviour. (see item 256)
|Rank=B
|Title=Knowing the risks associated with doping and doping behaviour
|Description=Institutional risks and health risks (pharmacological action of the molecule, development of addictive behaviour).
|Section=Monitoring and/or prognosis
|Contributors=
|Order=9}}
The use of doping products is likely to lead to

* institutional risks
* and ''health'' risks
** pharmacological action of the drug
** evolution towards <u>addictive behaviour</u>.